Treatment of Hair loss with polyherbal unani oil

Clinical study to assess the efficacy and safety of Rogan-i-Gesu Daraz in treating Intithar al-Sha r (hair loss) - a randomized, double-blind, standard controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080081

Enrollment

Registered

2025-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L659- Nonscarring hair loss, unspecified

Interventions

Intervention1: Rogan-i-Gesu Daraz: Form Oil Mode of application Topical Dosage Quantity sufficient once daily Follow up 0th 15th 30th 45th 60th Day after treatment Control Intervention1: Coconut oil:

Eligibility

Inclusion criteria

Inclusion criteria: An individual who tests positive on a hair pull test and has a history of hair loss Individuals who are willing to voluntarily provide informed consent to participate in the trial

Exclusion criteria

Exclusion criteria: pregnant or currently lactating women participants with prior systemic disorders participants with scalp lesions participants not on any others treatment options

Design outcomes

Primary

Measure	Time frame
5-point Likert scale (hair growth, hair count, hair thickness, and hair shining) visual analogue scale (VAS)Timepoint: Primary outcome will be measured at every follow up	—

Secondary

Measure	Time frame
Global photographic assessment Hair Loss Impact QuestionnaireTimepoint: Measured at baseline and end of the treatment	—

Countries

India

Contacts

Public ContactDr Mamdapur Saba Abdul Razzak

Luqman unani medical collage Hospital and research centre 12 Naubagh Vijayapura karnataka

drdafedar1@gmail.com9032786832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026